UBS Group’s Alpha Healthcare Acquisition Corp III Units ALPAU Stock Holding History

UBS Group’s Portfolio ALPAU Stock Details ALPAU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,545	Closed	-$15.3K	–	11104
2022 Q4	$15.3K	Sell	1,545 -308	-17%	-$3.03K	﹤0.01%	7996
2022 Q3	$18K	Buy	1,853 +100	+6%	+$978	﹤0.01%	7559
2022 Q2	$17K	Sell	1,753 -100	-5%	-$980	﹤0.01%	7149
2022 Q1	$18K	Buy	+1,853	New	+$18.2K	﹤0.01%	7608

Other funds holding ALPAU

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

LCM

Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

LIM

Longfellow Investment Management Boston, Massachusetts $480M AUM 8% 1-Year Est. Return

UBS Group's ALPAU Position: Q1 2023 in Review

UBS Group sold out of Alpha Healthcare Acquisition Corp III Units (ALPAU) in Q1 2023, closing a stake of 1,545 shares — an estimated $15.3K sold.

UBS Group first reported a position in ALPAU in Q1 2022 and held it in 4 quarters. The position peaked at $18K in Q3 2022. 6 funds tracked by Wall St. Rank hold ALPAU as of Q1 2023.

UBS Group reported no remaining Alpha Healthcare Acquisition Corp III Units position as of Q1 2023 after selling out during the quarter.
UBS Group sold 1,545 Alpha Healthcare Acquisition Corp III Units shares in Q1 2023, an estimated $15.3K.
UBS Group first reported a position in Alpha Healthcare Acquisition Corp III Units in Q1 2022 and held it in 4 quarters.
UBS Group's Alpha Healthcare Acquisition Corp III Units position peaked at $18K in Q3 2022.
6 funds tracked by Wall St. Rank held Alpha Healthcare Acquisition Corp III Units as of Q1 2023.

Based on UBS Group's 13F filing for Q1 2023, filed 12 May 2023.